222 related articles for article (PubMed ID: 9686407)
1. Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications.
Toll L; Berzetei-Gurske IP; Polgar WE; Brandt SR; Adapa ID; Rodriguez L; Schwartz RW; Haggart D; O'Brien A; White A; Kennedy JM; Craymer K; Farrington L; Auh JS
NIDA Res Monogr; 1998 Mar; 178():440-66. PubMed ID: 9686407
[No Abstract] [Full Text] [Related]
2. Evaluation of new compounds for opioid activity (1983).
Woods JH; Winger GD; Medzihradsky F; Smith CB; Katz JL
NIDA Res Monogr; 1984 Mar; 49():361-7. PubMed ID: 6090918
[No Abstract] [Full Text] [Related]
3. The synthesis and pharmacological activity of two new derivatives of benzazocine.
Gutkowska B; Gumułka SW; Krzaścik P; Poppe I; Mészáros J; Makulska HE
Pol J Pharmacol Pharm; 1991; 43(2):153-63. PubMed ID: 1658757
[TBL] [Abstract][Full Text] [Related]
4. Cocaine, dopamine and the endogenous opioid system.
Kreek MJ
J Addict Dis; 1996; 15(4):73-96. PubMed ID: 8943583
[TBL] [Abstract][Full Text] [Related]
5. Testing and evaluation of opiate analgesics and antagonists.
Hahn EF
Methods Find Exp Clin Pharmacol; 1985 Jul; 7(7):373-81. PubMed ID: 2865415
[TBL] [Abstract][Full Text] [Related]
6. Atypical 5-HT receptors in guinea-pig isolated ileum.
Wardle KA; Sanger GJ
Br J Pharmacol; 1989 Dec; 98 Suppl():801P. PubMed ID: 2611516
[No Abstract] [Full Text] [Related]
7. Neuronal sensitivity and opiate tolerance/dependence.
Herz A; Schulz R
Adv Neurol; 1982; 33():81-8. PubMed ID: 6119896
[No Abstract] [Full Text] [Related]
8. Structure-activity relationships in 1,4-benzodioxan-related compounds. 6. Role of the dioxane unit on selectivity for alpha(1)-adrenoreceptor subtypes.
Quaglia W; Pigini M; Piergentili A; Giannella M; Marucci G; Poggesi E; Leonardi A; Melchiorre C
J Med Chem; 1999 Jul; 42(15):2961-8. PubMed ID: 10425105
[TBL] [Abstract][Full Text] [Related]
9. Studies on the pharmacology of the novel histamine H3 receptor agonist Sch 50971.
Hey JA; Aslanian R; Bolser DC; Chapman RW; Egan RW; Rizzo CA; Shih NY; Fernandez X; McLeod RL; West R; Kreutner W
Arzneimittelforschung; 1998 Sep; 48(9):881-8. PubMed ID: 9793613
[TBL] [Abstract][Full Text] [Related]
10. The nature of opiate dependence.
Villarreal JE; Herrera JE; Salazar LA
Proc West Pharmacol Soc; 1985; 28():43-6. PubMed ID: 2999810
[No Abstract] [Full Text] [Related]
11. The effect of papaverine on acute opiate withdrawal in guinea pig ileum.
Capasso A; Loizzo A
Phytother Res; 2003 Aug; 17(7):774-7. PubMed ID: 12916076
[TBL] [Abstract][Full Text] [Related]
12. Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone].
Ananthan S; Khare NK; Saini SK; Seitz LE; Bartlett JL; Davis P; Dersch CM; Porreca F; Rothman RB; Bilsky EJ
J Med Chem; 2004 Mar; 47(6):1400-12. PubMed ID: 14998329
[TBL] [Abstract][Full Text] [Related]
13. Genetic determinants of addiction to opioids and cocaine.
Saxon AJ; Oreskovich MR; Brkanac Z
Harv Rev Psychiatry; 2005; 13(4):218-32. PubMed ID: 16126608
[TBL] [Abstract][Full Text] [Related]
14. [The biological mechanisms underlying alcohol dependence].
Alling C
Lakartidningen; 1999 Jul; 96(28-29):3248-52. PubMed ID: 10434508
[TBL] [Abstract][Full Text] [Related]
15. Overview: medications development for the treatment of drug abuse.
Vocci F; Chiang CN; Cummings L; Hawks R
NIDA Res Monogr; 1995; 149():4-15. PubMed ID: 8775832
[TBL] [Abstract][Full Text] [Related]
16. Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions.
Kreek MJ; Schluger J; Borg L; Gunduz M; Ho A
J Pharmacol Exp Ther; 1999 Jan; 288(1):260-9. PubMed ID: 9862779
[TBL] [Abstract][Full Text] [Related]
17. Cocaine abuse: neurochemistry, phenomenology, and treatment.
Gold MS; Washton AM; Dackis CA
NIDA Res Monogr; 1985; 61():130-50. PubMed ID: 3932873
[No Abstract] [Full Text] [Related]
18. Novel pharmacotherapeutic approaches for the treatment of drug addiction and craving.
Heidbreder CA; Hagan JJ
Curr Opin Pharmacol; 2005 Feb; 5(1):107-18. PubMed ID: 15661634
[TBL] [Abstract][Full Text] [Related]
19. A shared neuroimmunological mechanism for drugs of addiction?
Petitto JM
J Neuroimmunol; 2006 Apr; 173(1-2):1-2. PubMed ID: 16469391
[No Abstract] [Full Text] [Related]
20. Rat anococcygeus: a dynamic smooth muscle preparation for experimental pharmacology.
Kulkarni SK; Sharma A
Methods Find Exp Clin Pharmacol; 1994; 16(6):379-85. PubMed ID: 7837828
[No Abstract] [Full Text] [Related]
[Next] [New Search]
